Brief: Radiopharm Theranostics Receives IND Approval From US FDA For Betabart (Rv-01)
28/07/2025 01:06
July 28 (Reuters) - Radiopharm Theranostics Ltd RAD.AX: RAD RECEIVES IND APPROVAL FROM US FDA FOR BETABART (RV-01) Further company coverage: RAD.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Radiopharm Theranostics
See all newsNASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Radiopharm Theranostics To Meet With U.S. FDA To Align On Pivotal Phase 3 Trial Design For Rad 101 In Diagnosis Of Brain Metastases
NASDAQ RESUMED AT 09:56 AM
NASDAQ TRADE HALT CONTINUES VOLATILITY TRADING PAUSE AT 09:50 AM